| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 21 |
| 1 | PACLITAXEL | 18 |
| 2 | PACLITAXEL (AIBUMIN-BOUND) | 18 |
| 3 | PEMBROLIZUMAB | 16 |
| 4 | PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF | 16 |
| 5 | CYCLOPHOSPHAMIDE | 13 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 13 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 13 |
| 8 | LEVETIRACETAM | 13 |
| 9 | LEVETIRACETAM IN SODIUM CHLORIDE | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF | 16 | 0.0033 |
| 1 | ESLICARBAZEPINE ACETATE | 7 | 0.0021 |
| 2 | CEFADROXIL | 1 | 0.0005 |
| 3 | PROPAFENONE | 2 | 0.0005 |
| 4 | ADO-TRASTUZUMAB EMTANSINE | 3 | 0.0004 |
| 5 | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | 1 | 0.0003 |
| 6 | GOSERELIN | 4 | 0.0003 |
| 7 | MEGESTROL ACETATE | 1 | 0.0003 |
| 8 | ACETAMINOPHEN, DEXTROMETHORPHAN HBR | 1 | 0.0002 |
| 9 | PACLITAXEL | 18 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Microtubule Inhibitor [EPC] | 28 | 0.0002 |
| 1 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 3 | 0.0001 |
| 2 | HER2/neu Receptor Antagonist [EPC] | 7 | 0.0001 |
| 3 | Platinum-based Drug [EPC] | 21 | 0.0001 |
| 4 | Alkylating Drug [EPC] | 13 | 0.0001 |
| 5 | Progesterone [EPC] | 1 | 0.0000 |
| 6 | Cardiac Glycoside [EPC] | 3 | 0.0000 |
| 7 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 3 | 0.0000 |
| 9 | Cholinergic Muscarinic Antagonist [EPC] | 1 | 0.0000 |